Evaluating the best timing for surgery after heart attacks with ventricular defects
Multicenter Study on Post-acute Myocardial Infarction Ventricular Defect: Outcome Evalutation in Relation to Surgical Timing
This study is testing the best timing for surgery in people who have heart defects after a heart attack to see how it affects their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 4 sites (Bologna, Bologna and 3 other locations) |
| Trial ID | NCT06799780 on ClinicalTrials.gov |
What this trial studies
This study aims to determine the optimal timing for surgical intervention in patients who have developed intraventricular defects following an acute myocardial infarction. It will analyze the time interval between the diagnosis of these defects and the surgical treatment to assess outcomes. By observing patients who have undergone surgery, the study seeks to provide insights into the best practices for managing this condition. The findings could help refine surgical protocols and improve patient care.
Who should consider this trial
Good fit: Ideal candidates include adults over eighteen who have undergone surgical treatment for post-myocardial infarction ventricular septal defects.
Not a fit: Patients who have not undergone surgical treatment or whose defects are not related to acute myocardial infarction may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and recovery for patients with post-myocardial infarction ventricular defects.
How similar studies have performed: While there may be studies on surgical timing for other cardiac conditions, this specific focus on post-myocardial infarction ventricular defects is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over eighteen years of age * Patients with post-myocardial infarction ventricular septal defect treated surgically * Patients who have signed the informed consent Exclusion Criteria: * Patients with post-infarction ventricular septal defect treated with medical/conservative therapy * Patients with ventricular septal defects not due to acute myocardial infarction
Where this trial is running
Bologna, Bologna and 3 other locations
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (Recruiting)
- Ospedale Santa Maria della Misericordia Udine — Udine, Udine, Italy (Recruiting)
- Ospedale di Circolo e Fondazione Macchi Varese — Varese, Varese, Italy (Recruiting)
- Hospital Clinic Barcellona — Barcelona, Barcellona, Spain (Recruiting)
Study contacts
- Principal investigator: Luca Di Marco, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Luca Di Marco, MD
- Email: luca.dimarco@aosp.bo.it
- Phone: 0512149044
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.